METB-10. EVALUATION OF NON-SUPERVISED MATRIX-ASSISTED LASER DESORPTION / IONIZATION MASS SPECTROMETRY IMAGING (MALDI) MASS SPECTROMETRY IMAGING (MSI) COMBINED WITH MICROPROTEOMICS FOR DETERMINATION OF GLIOBLASTOMA HETEROGENEITY
Émilie Le Rhun(University of Zurich), Isabelle Fournier(The University of Texas MD Anderson Cancer Center), Marie Duhamel(Inserm), Michel Salzet(Laboratoire Pluridisciplinaire de Recherche en Ingénierie des Systèmes, Mécanique et Energétique), Nicolas Reyns(Centre National de la Recherche Scientifique), Fabienne Escande(Université de Lille), Maxence Wisztoski(Inserm), Fahed Zaïri(Inserm), Claude Alain Maurage(Centre National de la Recherche Scientifique), Lauranne Drelich(Inserm)
Cited by 1
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994